AIM:To examine the calcium metabolism of colorectal cancer (CRC)in patients with colorectal cancer and control patients. METHODS:Seventy newly diagnosed CRC patients were included.The healthy control group was age and...AIM:To examine the calcium metabolism of colorectal cancer (CRC)in patients with colorectal cancer and control patients. METHODS:Seventy newly diagnosed CRC patients were included.The healthy control group was age and gender matched(n=32).Particular attention was devoted to the relationship between serum calcium of patients,and levels of AFP,CEA,carbohydrate antigen 19-9(CA 19-9)(that could be considered as prognostic factors).Furthermore,the Ca-sensing receptor(CaSR)gene A986S polymorphism was investigated in these patients,as well as the relationship between different CaSR genotypes and the data stated above. RESULTS:A lower level of ionized calcium(also corrected for albumin)was found in the serum of CRC patients with normal 25(OH)vitamin D levels.The ionized calcium concentration was inversely correlated with the serum level of CA.19-9.There was no difference in the distribution of CaSR genotypes,between CRC patients and general population.The genotypes did not correlate with other data examined. CONCLUSION:Based on these results,lower levels of serum calcium might be a pathogenic and prognostic factor in colorectal cancer.展开更多
Background Currently,all frequently used staging systems in gallbladder cancer （GBC） are based on postoperative pathological examinations.In patients undergoing curative operation,there is no effective method to pre...Background Currently,all frequently used staging systems in gallbladder cancer （GBC） are based on postoperative pathological examinations.In patients undergoing curative operation,there is no effective method to predict survival preoperatively.In this study,we explored whether a combined utilization of two tumor biomarkers,namely carbohydrate antigen 19-9 （CA 19-9） and carcinoembryonic antigen （CEA）,could give a preoperative prediction of survival in resectable GBC.Methods Seventy-three patients who underwent radical resection for GBC were included in this study.A retrospective analysis of clinical-pathological data was conducted.Results By multivariate analysis,CA 19-9 elevation （P ＜0.05） and CEA elevation （P ＜0.001） were discovered as two individual factors for postoperative survival.By a combined utilization,patients were divided into three groups：patients with elevation of CEA （group Ⅰ）,patients with elevation of CA 19-9 but without CEA （group Ⅱ）,and patients with nonelevations of either CA 19-9 or CEA （group Ⅲ）.The cumulative 5-year survival rates in groups Ⅰ,Ⅱ,and Ⅲ were 0,14.0％,and 42.8％,respectively （P ＜0.05）.Conclusions By a combined utilization of CA 19-9 and CEA,individualized prediction of survival is available in resectable GBC before operation.Extended radical operation brings the most prognostic benefits in patients with nonelevations of either CA 19-9 or CEA.However,if operation would be in a larger-scale destructive manner,careful consideration of surgical decisions should be made in patients with elevation of tumor biomarkers,especially CEA.展开更多
目的：探讨血清糖类抗原125（CA125）及CA125联合CA199、CA153、癌胚抗原（CEA）检测在卵巢癌诊断中的意义。方法：采用化学发光微粒子免疫检测法测定71例卵巢癌患者、10例卵巢交界性肿瘤患者和42例卵巢良性肿瘤患者血清中CA125、CA199...目的：探讨血清糖类抗原125（CA125）及CA125联合CA199、CA153、癌胚抗原（CEA）检测在卵巢癌诊断中的意义。方法：采用化学发光微粒子免疫检测法测定71例卵巢癌患者、10例卵巢交界性肿瘤患者和42例卵巢良性肿瘤患者血清中CA125、CA199、CA153和CEA的含量,阳性诊断标准分别为：CA125〉35 k U/L,CA199〉37 k U/L,CA153〉30 k U/L,CEA〉5μg/L。结果：在单项肿瘤标记物中,CA125的阳性率最高（84.5%）,敏感度、特异度和准确度指标平稳。在不同的联合检测方案中CA199、CA153与CA125联合检测方案最优,较CA125单项检测敏感度和准确度均有提高。晚期卵巢癌（Ⅲ～Ⅳ期）患者的CA153、CA125含量高于早期卵巢癌（Ⅰ～Ⅱ期）患者（P〈0.001）。结论：CA199、CA153、CEA与CA125在卵巢癌鉴别诊断中均有一定价值,并可以根据CA153、CA125含量判断患者卵巢癌的分期,CA199、CA153与CA125联合检测是诊断卵巢癌较为理想的标记物组合。展开更多
文摘AIM:To examine the calcium metabolism of colorectal cancer (CRC)in patients with colorectal cancer and control patients. METHODS:Seventy newly diagnosed CRC patients were included.The healthy control group was age and gender matched(n=32).Particular attention was devoted to the relationship between serum calcium of patients,and levels of AFP,CEA,carbohydrate antigen 19-9(CA 19-9)(that could be considered as prognostic factors).Furthermore,the Ca-sensing receptor(CaSR)gene A986S polymorphism was investigated in these patients,as well as the relationship between different CaSR genotypes and the data stated above. RESULTS:A lower level of ionized calcium(also corrected for albumin)was found in the serum of CRC patients with normal 25(OH)vitamin D levels.The ionized calcium concentration was inversely correlated with the serum level of CA.19-9.There was no difference in the distribution of CaSR genotypes,between CRC patients and general population.The genotypes did not correlate with other data examined. CONCLUSION:Based on these results,lower levels of serum calcium might be a pathogenic and prognostic factor in colorectal cancer.
文摘Background Currently,all frequently used staging systems in gallbladder cancer （GBC） are based on postoperative pathological examinations.In patients undergoing curative operation,there is no effective method to predict survival preoperatively.In this study,we explored whether a combined utilization of two tumor biomarkers,namely carbohydrate antigen 19-9 （CA 19-9） and carcinoembryonic antigen （CEA）,could give a preoperative prediction of survival in resectable GBC.Methods Seventy-three patients who underwent radical resection for GBC were included in this study.A retrospective analysis of clinical-pathological data was conducted.Results By multivariate analysis,CA 19-9 elevation （P ＜0.05） and CEA elevation （P ＜0.001） were discovered as two individual factors for postoperative survival.By a combined utilization,patients were divided into three groups：patients with elevation of CEA （group Ⅰ）,patients with elevation of CA 19-9 but without CEA （group Ⅱ）,and patients with nonelevations of either CA 19-9 or CEA （group Ⅲ）.The cumulative 5-year survival rates in groups Ⅰ,Ⅱ,and Ⅲ were 0,14.0％,and 42.8％,respectively （P ＜0.05）.Conclusions By a combined utilization of CA 19-9 and CEA,individualized prediction of survival is available in resectable GBC before operation.Extended radical operation brings the most prognostic benefits in patients with nonelevations of either CA 19-9 or CEA.However,if operation would be in a larger-scale destructive manner,careful consideration of surgical decisions should be made in patients with elevation of tumor biomarkers,especially CEA.
文摘目的：探讨血清糖类抗原125（CA125）及CA125联合CA199、CA153、癌胚抗原（CEA）检测在卵巢癌诊断中的意义。方法：采用化学发光微粒子免疫检测法测定71例卵巢癌患者、10例卵巢交界性肿瘤患者和42例卵巢良性肿瘤患者血清中CA125、CA199、CA153和CEA的含量,阳性诊断标准分别为：CA125〉35 k U/L,CA199〉37 k U/L,CA153〉30 k U/L,CEA〉5μg/L。结果：在单项肿瘤标记物中,CA125的阳性率最高（84.5%）,敏感度、特异度和准确度指标平稳。在不同的联合检测方案中CA199、CA153与CA125联合检测方案最优,较CA125单项检测敏感度和准确度均有提高。晚期卵巢癌（Ⅲ～Ⅳ期）患者的CA153、CA125含量高于早期卵巢癌（Ⅰ～Ⅱ期）患者（P〈0.001）。结论：CA199、CA153、CEA与CA125在卵巢癌鉴别诊断中均有一定价值,并可以根据CA153、CA125含量判断患者卵巢癌的分期,CA199、CA153与CA125联合检测是诊断卵巢癌较为理想的标记物组合。
